Anna Jeanne Lizzul

Anna Jeanne Lizzul asked for insights into Methodic's outlook for 2026, specifically regarding new customer acquisition strategies compared to SpoiledChild and Il Makiage. Lizzul also questioned the impact of new brand investments on SG&A for Q4 2025 and early 2026.

Answer

Oran Holtzman, Co-founder and CEO, ODDITY, stated expectations for Methodic to scale faster than SpoiledChild, though its initial revenue contribution will be small. Lindsay Drucker Mann, CFO, ODDITY, expressed long-term bullishness for Methodic, highlighting its focus on dermatology and leveraging existing user data. She clarified that SG&A guidance is conservative to allow flexibility for growth initiatives, with investments planned for Q4 and H1 2026.

Anna Jeanne Lizzul asked about potential retailer destocking trends and Clorox's exposure, especially given the ERP transition. She also inquired about increasing exposure to club and online channels, particularly for Glad, and any innovation tailored for these retailers or new pack sizes. Additionally, she sought thoughts on private label share growth, specifically in categories like wipes.

Answer

CEO Linda Rendle confirmed that the ERP implementation led to inventory rebuilding, so Clorox is not experiencing material destocking, and inventories are largely recovered. She noted a strong club business with specific innovation for members, acknowledging Glad has less club presence but strong distribution elsewhere for large sizes. On private label, she stated no material aggregate inroads, but highlighted Brita filters and bleach as categories being carefully watched for private label uptick, while the cleaning portfolio generally performs well against private label.